Get started
Author

David Straus

Observed names: D. Straus, David S. Straus
OpenAlex ID: A5111736637
Ifosfamide, Carboplatin, and Etoposide: A Highly Effective Cytoreduction and Peripheral-Blood Progenitor-Cell Mobilization Regimen for Transplant-Eligible Patients With Non-Hodgkin's Lymphoma
1999 · Craig H. Moskowitz, Joseph R. Bertino, et al. · Journal of Clinical Oncology · 302
Primary gastrointestinal lymphoma:A 30-year review
1982 · Daniel N. Weingrad, Jerome J. Decosse, et al. · Cancer · 240
PDF
Cyclophosphamide/Fludarabine (CF) is Active in the Treatment of Mantle Cell Lymphoma
2001 · Bradley J. Cohen, Cràig Moskowitz, et al. · Leukemia & lymphoma/Leukemia and lymphoma · 75
R-CHOP-14 in patients with diffuse large B-cell lymphoma: Feasibility and preliminary efficacy
2005 · Jeffrey L Halaas, Craig H Moskowitz, et al. · Leukemia & lymphoma/Leukemia and lymphoma · 42
Chemotherapy for Hiv-associated Non-hodgkin Lymphoma (hiv-nhl) in Combination With Highly Active Antiretroviral Therapy (haart) Is Not Associated With Excessive Toxicity.
1999 · L. Ratner, D. Redden, et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 20
Schedule of bortezomib administration may be an important determinant of single-agent activity in patients with relapsed or refractory follicular (FL) lymphoma and mantle cell lymphoma (MCL)
2007 · O. O'Connor, P. Hamlin, et al. · Journal of Clinical Oncology · 10
Doxorubicin, Vinblastine and Gemcitabine (AVG), a Novel Regimen Excluding Bleomycin for the Treatment of Early Stage Hodgkin Lymphoma (HL): Results of CALGB 50203.
2007 · David Straus, Ann LaCase, et al. · Blood · 8
S820 Frontline Brentuximab Vedotin With Chemotherapy for Stage 3/4 Classical Hodgkin Lymphoma: 3‐year Update of the Echelon‐1 Study
2019 · A. Gallamini, D. Straus, et al. · HemaSphere · 3
HL-507 First-Line Brentuximab Vedotin Plus Chemotherapy Improves Overall Survival in Patients With Stage III/IV Classical Hodgkin Lymphoma: An Updated Analysis of ECHELON-1
2022 · David Straus, John Radford, et al. · Clinical Lymphoma Myeloma & Leukemia · 1
Defining Progression Free Survival After Multiple Lines of Therapy and Impact of Dynamic Changes in Flipi for Multiply Relapsed Follicular Lymphoma in the Rituximab Era
2017 · C. Batlevi, A. Alperovich, et al. · Hematological Oncology · 1
PDF
2038 Autologous bone marrow transplantation following high-dose chemotherapy with or without accelerated hyperfractionated total lymphoid irradiation for patients with refractory or relapsed Hodgkin's disease
1995 · Janaki Moni, Joachim Yahalom, et al. · International Journal of Radiation Oncology*Biology*Physics
Works count: 12
Citation count: 702
H-index: 7
I10-index: 6
Year
Topic
Type